Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CureVac N.V (CVAC) Equity Average: 2024-2025

  • CureVac N.V's Equity Average rose 1.82% to $2.3 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $2.3 billion, marking a year-over-year increase of 1.82%. This contributed to the annual value of $650.3 million for FY2024, which is 18.21% up from last year.
  • Per CureVac N.V's latest filing, its Equity Average stood at $2.3 billion for Q2 2025, which was up 54.80% from $1.5 billion recorded in Q1 2025.
  • In the past 5 years, CureVac N.V's Equity Average registered a high of $2.3 billion during Q2 2025, and its lowest value of $1.4 billion during Q1 2024.
  • Its 2-year average for Equity Average is $1.8 billion, with a median of $1.8 billion in 2024.
  • Data for CureVac N.V's Equity Average shows a peak YoY rose of 4.92% (in 2025) over the last 5 years.
  • CureVac N.V's Equity Average (Quarterly) stood at $2.2 billion in 2024, then climbed by 1.82% to $2.3 billion in 2025.
  • Its Equity Average stands at $2.3 billion for Q2 2025, versus $1.5 billion for Q1 2025 and $2.2 billion for Q2 2024.